• About Us
  • Contact
FNN
  • News Categories
    • Company News
    • Interviews
    • Market Reports
    • Stock Watch
    • Company Presentations
    • Funds Management
  • Funds Management
    • Acorn Capital
      • Acorn Capital Investment Fund
    • Altrinsic
      • Altrinsic Global Advisors
    • Antares
      • Antares Australian Equities Fund
      • Antares Dividend Builder
      • Antares Elite Opportunities Fund
      • Antares Fixed Income Fund
      • Antares Listed Property Fund
    • Ausbil
      • Ausbil 130/30 Focus Fund
      • Ausbil Active Sustainable Equity Fund
      • Ausbil Australian Active Equity Fund
      • Ausbil Australian Emerging Leaders Fund
      • Ausbil MicroCap Fund
    • Capital Property Funds
      • Capital Property Funds
    • Fairview
      • Fairview Equity Partners Emerging Companies
    • Hunter Hall
      • Hunter Hall Global Value
    • Intermede
      • Intermede Global Equities Fund
    • MLC
      • MLC Inflation Plus
    • Presima
      • Presima Global Property Securities Concentrated Fund
    • ResiFund
      • ResiFund
    • Ruffer
      • Ruffer
    • Russell Investments
      • Russell Investments
    • Tribeca Investment Partners
      • Tribeca Investment Partners
    • VanEck
      • VanEck
  • Expert Insights
    • Jeffrey Liu
    • Michael Gable
    • Patrick Taylor
  • Media Releases
  • Investor Events
    • FNN Events

Media Releases › SUDA Pharmaceuticals

View All SUDA Pharmaceuticals News


Reinstatement to Official Quotation

25 Jun 2020 10:37 AM


For more information, please refer to the attached PDF
 Download this document

Subscribe

Subscribe for our daily email digest

Company Directors

  • Dr Michael Baker (CEO)
  • Mr Joseph Ohayon (CFO)
  • Mr Paul Hopper (Executive Chairman)
  • Mr David Phillips (Executive Director)
  • Mr David Simmonds (Non-Executive Director)

Contact Information

  • (08) 6142 5555
  • http://www.sudaltd.com.au
  • Level 1, Unit 12, 55 Howe Street, OSBORNE PARK, WA, Australia, 6017

Latest Company News

Youfoodz (ASX:YFZ) posts strong quarter 2 growth and reaffirms prospectus forecast

3 hours ago

PointsBet (ASX:PBH) appoints Shaquille ONeal as Australian Brand Ambassador

3 hours ago

Ampol (ASX:ALD) successfully completes $300 million off-market share buy-back

4 hours ago

First patients dosed in Telix Pharmaceutical's (ASX:TLX) Phase 3 US trial

4 hours ago

Blackstone Minerals (ASX:BSX) in talks with Trafigura

3 days ago

Beacon Lighting Group (ASX:BLX) subfund to acquire WA showroom

3 days ago

Latest Media Releases

QEM - Quarterly Activities Report

2 hours ago

QEM - Quarterly Cashflow Report

2 hours ago

Nyrada Reports Further Results from Cholesterol Study

4 hours ago

Altech Chemicals - Battery Performance Tests Using HPA Coated Graphite

5 hours ago

Cyclopharm - Proposed issue of Securities

6 hours ago

Cyclopharm Capital Raising Presentation

6 hours ago

Cyclopharm Successfully Completes A$30 Million Placement

6 hours ago

SUDA Pharmaceuticals - Quarterly Appendix 4C and Activities Report

6 hours ago

SUDA Pharmaceuticals - Zolpimist Update

7 hours ago

Cyclopharm - SNMMI Requests USFDA to Expedite Approval For Technegas

3 days ago

Recent Insights

Growth Focus: Neometals Ltd (NMT)

17/12/2020 15:04

Post-Covid Wealth Management Strategy

17/12/2020 12:07

Jeffrey Liu

16/12/2020 12:40

Growth Focus: SRG Global Ltd (SRG)

05/12/2020 15:42

Growth Focus: New Century Zinc Ltd (NCZ)

09/11/2020 15:41

FNN

ABN 31 117 966 328
Disclaimer
Privacy Policy

Categories

  • Company News
  • Market Reports
  • Interviews
  • Presentations
  • Funds Management

Newsletter

Receive Daily News to your email

Recent Companies

  • ASX:ALD
  • ASX:ALL
  • ASX:CCL
  • ASX:LYC
  • ASX:FPH
  • ASX:WES
  • ASX:URW
  • ASX:APT
  • ASX:SOL
  • ASX:ANN
  • ASX:APT
  • Nasdaq:AFRM
  • ASX:PYR
  • ASX:PME
  • ASX:CUV
  • ASX:RSG
  • ASX:PNV
  • ASX:Z1P
  • ASX:AUB
  • ASX:BIN
  • ASX:BLX
  • ASX:BSX
  • ASX:CBA
  • ASX:WBC
  • ASX:FMG
  • ASX:BHP
  • ASX:OSH
  • ASX:WPL
  • ASX:CWN
  • ASX:AUK
  • ASX:CDV
  • ASX:CIP
  • ASX:NIC
  • ASX:COF
  • ASX:BLD
  • ASX:CWY
  • ASX:INR
  • ASX:MLT
  • ASX:CYC
  • ASX:PLS
  • ASX:WHC
  • ASX:PLL
  • ASX:DMP
  • ASX:NVX
  • ASX:DOW
  • ASX:TLS
  • ASX:GLL
  • ASX:NCM
  • ASX:TYR
  • ASX:NOX

Copyright Finance TV Pty Ltd All Rights Reserved

  • Home
  • News Categories
    • Company News
    • Interviews
    • Market Reports
    • Stock Watch
    • Company Presentations
    • Funds Management
  • Funds Management
    • Acorn Capital
      • Acorn Capital Investment Fund
    • Altrinsic
      • Altrinsic Global Advisors
    • Antares
      • Antares Australian Equities Fund
      • Antares Dividend Builder
      • Antares Elite Opportunities Fund
      • Antares Fixed Income Fund
      • Antares Listed Property Fund
    • Ausbil
      • Ausbil 130/30 Focus Fund
      • Ausbil Active Sustainable Equity Fund
      • Ausbil Australian Active Equity Fund
      • Ausbil Australian Emerging Leaders Fund
      • Ausbil MicroCap Fund
    • Capital Property Funds
      • Capital Property Funds
    • Fairview
      • Fairview Equity Partners Emerging Companies
    • Hunter Hall
      • Hunter Hall Global Value
    • Intermede
      • Intermede Global Equities Fund
    • MLC
      • MLC Inflation Plus
    • Presima
      • Presima Global Property Securities Concentrated Fund
    • ResiFund
    • Ruffer
    • Russell Investments
    • Tribeca Investment Partners
    • VanEck
  • Expert Insights
    • Jeffrey Liu
    • Michael Gable
    • Patrick Taylor
  • Media Releases
  • Investor Events
    • FNN Events